Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFaron Pharma Share News (FARN)

Share Price Information for Faron Pharma (FARN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 150.00
Bid: 140.00
Ask: 160.00
Change: 5.00 (3.45%)
Spread: 20.00 (14.286%)
Open: 150.00
High: 150.00
Low: 150.00
Prev. Close: 145.00
FARN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK earnings, trading statements calendar - next 7 days

Thu, 18th Mar 2021 16:06

Friday 19 March 
Sanne Group PLCFull Year Results
Investec PLCTrading Statement
Johnson Service Group PLCFull Year Results
JD Wetherspoon PLCHalf Year Results
ContourGlobal PLCFull Year Results
Monday 22 March 
Blackbird PLCFull Year Results
Yew Grove REIT PLCFull Year Results
Centamin PLCFull Year Results
Kingfisher PLCFull Year Results
SDX Energy PLCFull Year Results
Tuesday 23 March 
accesso Technology Group PLCFull Year Results
Alliance Pharma PLCFull Year Results
Arrow Global Group PLCFull Year Results
Cambridge Cognition PLCFull Year Results
DP Eurasia NVFull Year Results
Elementis PLCFull Year Results
Energean PLCFull Year Results
essensys PLCFull Year Results
Fintel PLCFull Year Results
Gamma Communications PLCFull Year Results
H&T Group PLCFull Year Results
Henry Boot PLCFull Year Results
Judges Scientific PLCFull Year Results
Longboat Energy PLCFull Year Results
LoopUp Group PLCFull Year Results
Luceco PLCFull Year Results
Malin Corp PLCFull Year Results
McColl's Retail Group PLCFull Year Results
MJ Hudson Group PLCHalf Year Results
Mortgage Advice Bureau Holdings PLCFull Year Results
MP Evans Group PLCFull Year Results
Old Mututal LtdFull Year Results
Personal Group Holdings PLCFull Year Results
YouGov PLCFull Year Results
Zotefoams PLCFull Year Results
Wednesday 24 March 
Softcat PLCHalf Year Results
Circassia Group PLCFull Year Results
Burford Capital LtdFull Year Results
Sopheon PLCFull Year Results
Strix Group PLCFull Year Results
TClarke PLCFull Year Results
Keywords Studios PLCFull Year Results
ECSC Group PLCFull Year Results
Telit Communications PLCFull Year Results
Bellway PLCHalf Year Results
Diploma PLCTrading Statement
Anglo Pacific Group PLCFull Year Results
Frontier IP Group PLCHalf Year Results
Pendragon PLCFull Year Results
Applied Graphene Materials PLCHalf Year Results
Kenmare Resources PLCFull Year Results
Thursday 25 March 
Allied Minds PLCFull Year Results
Arbuthnot Banking Group PLCFull Year Results
BBGI Global Infrastructure SAFull Year Results
Biome Technologies PLCFull Year Results
Cineworld Group PLCFull Year Results
Compass Group PLCTrading Statement
CVS Group PLCHalf Year Results
EnQuest PLCFull Year Results
Equiniti Group PLCFull Year Results
Faron Pharmaceuticals OyFull Year Results
Funding Circle Holdings PLCFull Year Results
Genedrive PLCHalf Year Results
International Public Partnerships LtdFull Year Results
IQE PLCFull Year Results
Lamprell PLCFull Year Results
Learning Technologies Group PLCFull Year Results
Pebble Group PLCFull Year Results
Robinson PLCFull Year Results
S4 Capital PLCFull Year Results
Safestyle UK PLCFull Year Results
SIG PLCFull Year Results
Surgical Innovations Group PLCFull Year Results
United Utilities Group PLCTrading Statement
  
Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
14 Mar 2022 14:14

IN BRIEF: Faron research sheds light on Covid-linked mutations

Faron Pharmaceuticals Ltd - Turku, Finland-based clinical-stage biopharmaceutical company - Publishes research expanding on analysis of a gene mutation in an interferon receptor that is linked to corticosteroid response and outcomes in acute respiratory distress syndrome and Covid-19 patients. Builds on Faron's findings from its phase III 'Interest' trial for Traumakine in ARDS patients. Traumakine is an investigational intravenous interferon beta-1a therapy.

Read more
4 Mar 2022 20:53

TRADING UPDATES: IOG to cut Gazprom ties; wholesale changes at Donegal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and Tuesday and not separately reported by Alliance News:

Read more
23 Feb 2022 20:11

TRADING UPDATES: BiVictriX expands development; Okyo wins US patent

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
23 Feb 2022 13:37

Faron upbeat on updated data from cancer treatment study

(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals announced updated survival data from the phase 1 and 2 study investigating the safety and efficacy of 'bexmarilimab' on Wednesday.

Read more
31 Jan 2022 14:49

EXECUTIVE CHANGES: Anglo Pacific promotes investment head to CEO

EXECUTIVE CHANGES: Anglo Pacific promotes investment head to CEO

Read more
4 Jan 2022 16:10

Marie-Louise Fjallskog tapped as Faron's new chief medical officer

(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals announced the appointment of Marie-Louise Fjällskog as its chief medical officer on Tuesday, to be based in Boston, Massachusetts and effective immediately.

Read more
4 Jan 2022 15:54

Faron appoints Sensei Biotherapeutics's Marie-Louise Fjallskog as CMO

Faron appoints Sensei Biotherapeutics's Marie-Louise Fjallskog as CMO

Read more
1 Dec 2021 15:59

EXECUTIVE CHANGES: GCP Infrastructure picks Rothschild banker as chair

EXECUTIVE CHANGES: GCP Infrastructure picks Rothschild banker as chair

Read more
9 Nov 2021 22:01

TRADING UPDATES: Shepherd Neame losses cut; Beximco to sell Covid pill

TRADING UPDATES: Shepherd Neame losses cut; Beximco to sell Covid pill

Read more
9 Nov 2021 11:23

Faron Pharmaceuticals wins dispute with Rentschler at tribunal

(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals announced on Tuesday that the arbitration tribunal appointed by the Arbitration Institute of the Stockholm Chamber of Commerce (SCC) had ruled in its favour in its case against Rentschler Biopharma.

Read more
1 Oct 2021 11:45

IN BRIEF: Faron Pharma raises EUR10.5 million in share placing

IN BRIEF: Faron Pharma raises EUR10.5 million in share placing

Read more
30 Sep 2021 18:06

IN BRIEF: Faron Pharma to raise at least EUR8 million via placing

IN BRIEF: Faron Pharma to raise at least EUR8 million via placing

Read more
17 Sep 2021 17:52

IN BRIEF: Faron Pharma hails updated results from Matins study

IN BRIEF: Faron Pharma hails updated results from Matins study

Read more
26 Aug 2021 14:56

TRADING UPDATES: Glenveagh, IOG swing to profit; Faron loss widens

TRADING UPDATES: Glenveagh, IOG swing to profit; Faron loss widens

Read more
25 Aug 2021 11:43

Faron doses first patient in Covid-19 treatment trial

(Sharecast News) - Clinical-stage biopharmaceuticals company Faron Pharmaceuticals announced on Wednesday that the first patient has been dosed in the phase 2 and 3 'HIBISCUS' trial, assessing 'Traumakine', or intravenous interferon beta-1a, as a first-line treatment for hospitalised Covid-19 patients.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.